Therapeutic Action
Thiazide diuretic
PDF page 163
Drug reference
Thiazide diuretic
PDF page 163
Hypertension Oedema associated with renal, hepatic or congestive heart failure
PDF page 163
Do not administer to patients with severe renal failure. Administer with caution in patients with hypokalaemia, hyponatraemia and in elderly patients. May cause: dehydration, hypotension, hypokalaemia, hyponatraemia; gastrointestinal disturbances, headache, dizziness, skin rash, impotence, photosensitivity. Avoid or monitor combination with NSAIDs (risk of renal impairment); lithium (increased plasma concentrations of lithium). Monitor combination with: drugs that provoke hypotension (e.g. haloperidol, amitriptyline) and antihypertensive drugs (risk of hypotension); potassium-depleting drugs (e.g. corticosteriods, laxatives, amphotericin B), sodium-depleting drugs (e.g. SSRI, carbamazepine), drugs enhancing hypercalcemic effect (e.g. calcium, ergocalciferol); oral antidiabetics and insulin (risk of hyperglycaemia). Pregnancy: CONTRA-INDICATED Breast-feeding: CONTRA-INDICATED
PDF pages 163, 164
12.5 mg and 25 mg tablets
PDF page 163
Hypertension Adult: 12.5 to 25 mg once daily in the morning (max. 25 mg daily) Oedema associated with renal, hepatic or congestive heart failure Adult: 25 mg once daily in the morning or 25 mg 2 times daily (max. 100 mg daily)
PDF page 163
According to clinical response
PDF page 163
A potassium-rich diet (dates, bananas, mangos, oranges, tomatoes, etc.) is recommended during treatment. If potassium level is < 3.5 mmol/litre, administer a sustained-released potassium supplement. Diuretics are not indicated in the treatment of nutritional oedema.
PDF page 164
- Below 25 °C
PDF page 164
12.5 to 25 mg once daily in the morning (max. 25 mg daily)
PDF page 163
25 mg once daily in the morning or 25 mg 2 times daily (max. 100 mg daily)
PDF page 163